首页> 外文期刊>Antioxidants and redox signalling >May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic parkinson's disease
【24h】

May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic parkinson's disease

机译:通过选择性增加3-硝基酪氨酸而不是硝酸白蛋白和显着的酪氨酸-酪氨酸-125/136亚硝化血清α-突触核蛋白来评估亚硝化应激可用于诊断散发性帕金森氏病

获取原文
获取原文并翻译 | 示例
           

摘要

Nitrosative stress, where nitrosylation of tyrosine (Tyr) leading to 3-nitrotyrosine proteins or free 3-nitrotyrosine is the most prominent change, has been proposed as a pathogenic mechanism in Parkinson's disease (PD). Levels of 3-nitrotyrosine proteins in serum and cerebrospinal fluid (CSF) of patients with PD have not been studied. Nitrosative stress-induced protein changes in serum and CSF were analyzed in patients with PD (n=54) and controls (n=40). Herein, we demonstrate the presence of nitrosative stress in serum and CSF of patients with early PD leading to selective increase of 3-nitrotyrosine proteins other than nitroalbumin, without free 3-nitrotyrosine (Hoehn-Yahr stage 1, p<0.05; stage 2, p<0.01). Among 3-nitrotyrosine proteins, nitro-α-synuclein (N-αSyn) was detected in serum, not CSF, and the sites of Tyr nitrosylation were observed to be modified in patients with early PD. Thus, the intensity of nitrosylation of Tyr125/136 residues is enhanced (stage 1, p<0.05; stage 2, p<0.01), and that of the Tyr39 site is reduced (stage 1, p<0.05), and the ratio between both parameters (α-synuclein with nitrosylated tyrosines 125 and 136 [N-αSyn-Tyr125/136]:α- synuclein with nitrosylated tyrosine 39 [N-αSyn-Tyr39] ratio) is significantly higher in patients with early PD (p<0.01). These observations lead to the hypothesis that evaluating nitrosative stress through enhanced levels of 3-nitrotyrosine proteins in serum and CSF without changes in nitroalbumin, together with the profile of tyrosine nitrosylation of serum αSyn characterized by dominant nitrosylation of Tyr125/136, could serve for the diagnosis of sporadic PD.
机译:已经提出亚硝化胁迫是酪氨酸(Tyr)的亚硝基化导致3-硝基酪氨酸蛋白或游离的3-硝基酪氨酸最显着的变化,它是帕金森氏病(PD)的致病机制。 PD患者血清和脑脊液(CSF)中的3-硝基酪氨酸蛋白水平尚未进行研究。在PD(n = 54)和对照组(n = 40)的患者中分析了亚硝酸盐诱导的血清和CSF蛋白变化。在此,我们证明了早期PD患者的血清和CSF中存在亚硝化应激,导致选择性合成了除了游离白蛋白以外的3-硝基酪氨酸,而没有游离3-硝基酪氨酸(Hoehn-Yahr阶段1,p <0.05;阶段2 p <0.01)。在3-硝基酪氨酸蛋白中,在血清中检测到硝基-α-突触核蛋白(N-αSyn),而非脑脊液,并且观察到早期PD患者的Tyr亚硝化位点被修饰。因此,增强了Tyr125 / 136残基的亚硝化强度(阶段1,p <0.05;阶段2,p <0.01),而Tyr39位点的亚硝基化强度降低(阶段1,p <0.05),并且早期PD患者的两个参数(α-突触核蛋白与亚硝化酪氨酸125和136 [N-αSyn-Tyr125/ 136]:α-突触核蛋白与亚硝化酪氨酸39 [N-αSyn-Tyr39]的比率)在PD早期患者中明显更高(p <0.01 )。这些观察结果得出这样的假设:通过提高血清和脑脊液中3-硝基酪氨酸蛋白的水平而不改变硝基白蛋白来评估亚硝化应激,以及以Tyr125 / 136的显性亚硝基化为特征的血清αSyn酪氨酸亚硝化的概况,可以为诊断散发性PD。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号